Introduction
Previous studies have demonstrated that environmental chemical contaminants impair host defense responses to a malaria challenge and to gram-negative endotoxin (1) . In conjunction with these alterations, a significant reduction in antibody formation to sheep erythrocytes, (SRBC), a T-dependent and macrophage-processed antigen, was observed (2) . These functional alterations were demonstrated in the absence of any lymphoid histopathologic changes. Further studies to examine cell-mediated immunity (CMI) in the xenobiotic treated mice revealed an essentially normal CMI responsiveness as measured by the graft-versushost assay, mixed lymphocyte culture reaction, February 1982 polyclonal mitogen activity and lymphocytotoxicity response (3) . Since it was felt that the CMI parameters which were measured and which were unaltered were, in general, macrophage-independent whereas the response to malaria, endotoxin and SRBC were macrophage-dependent, the cellular lesion responsible for the impaired malaria, endotoxin and SRBC responses could reside at the level of the macrophage.
Measurements of macrophage affector activity, i.e., cellular respiration, phagocytic activity, phagocytic capacity and chemotaxis revealed no alteration in these parameters (4) . However, macrophage effector activity, i.e., antigen processing and tumor cell killing were significantly impaired (5) . Therefore, it was speculated that if the cellular lesion responsible for the xenobiotic-induced immunosuppression was at the level of the macrophage, that the lesion could be due to: a functional impairment in the macrophage, induction of a population of suppressor macrophages, production of suppressor 89 factors from the macrophage or a combination of one of the above.
Therefore, further studies were conducted to determine the contribution of the macrophage to xenobiotics-induced immunosuppression. The possible development of a synergistic reaction between the influence of the xenobiotics on the immune response and a concomitant protozoan infection was ascertained concurrently.
Materials and Methods

Animals
Male BALB/c mice (18-20 g) were used throughout all studies.
Chemicals
Dieldrin (Shell) and hexachlorobenzene (HCB, Eastman) were administered in the diet at 1 and 5 ppm and 5 and 100 ppm, respectively. Control 
Antibody Formation
Antibody production was assessed using the direct Jerne and Nordin (6) plaque assay as previously described (2) . Plaque formation to polyvinylpyrrolidine (PVP, Sigma), a T-independent antigen, utilized passively sensitized SRBC coated with PVP by the method of Boyden (7) . Preliminary studies revealed that the kinetics of splenic plaque formation in experimental and control mice were compa-90 rable and, therefore, only day 4 was used to subsequently enumerate plaques.
Mononuclear Spleen Cell Populations
Splenic T-and B-lymphocytes were enumerated as previously described (8) . T-cells were detected by the presence of theta antigen (Thy-1) and subsequent cytotoxicity induced by anti-theta serum. B-cells were detected by the presence of surface immunoglobulin (Ig) using fluorescein-tagged, goat anti-mouse Ig. Splenic macrophages were stained by the method of Yam, Li and Crosby (9) , which detects the presence of surface neutral esterase, a cytochemical marker for macrophages.
Lymphocyte Blastogenesis
Spleens were removed aseptically from mice, controls and experimentals, at the stated intervals (see Tables 5-8) , and teased apart in cold RPMI 1640 and strained through a lOxx silk cloth. This single cell suspension was then passaged through nylon wool (Leuko-Pak leukocyte filter, Fenwal Labs, Deerfield, Ill.) which was soaked in saline for 2 hr at 37°C then rinsed three times in doubly distilled water for 3 days, autoclaved and then dried. A 60-ml disposable syringe barrel was then packed with 6 g of nylon wool and then washed with 20 ml of RPMI 1640 containing 5% fetal calf serum. The columns were then drained and placed in a 37°C incubator for 1 
Macrophage Assay
Alveolar, splenic and peritoneal macrophages were isolated as previously described (4) . Briefly, alveolar macrophages were isolated by lavage of the lung with saline, peritoneal macrophages were isolated by saline lavage of the peritoneal cavity, and splenic macrophages were isolated by surface adsorption. Hepatic Kupffer cells were isolated by partial enzymatic digestion of the liver as described by Stege et al. (10) Macrophage antigen processing of SRBC, a Tdependent antigen which requires macrophage cooperation for immunogenicity, was conducted as previously described (5).
Statistics
All data are reported as the mean with significance denoted by an asterisk where p < 0.05. Significance was determined by using the Student's t test. Significance for mortality data was calculated using the time-effect evaluation of Litchfield (11) .
Results
As can be seen in Table 1 , the addition of either 1 or 5 ppm of dieldrin to the diet of mice exacerbated the lethality induced by a challenge infection with either the malaria parasite Plasmodium berghei (NYU-2) or Leishmania tropica. The lethality synergized by dieldrin and the parasites appeared to be both time and dose related. However, mice administered 5 or 100 ppm of HCB and then challenged with malaria or Leishmania expressed a synergy only with Leishmania and not malaria. The mortality induced by Leishmania was more marked in dieldrin-exposed mice than in HCB-exposed mice.
When the dieldrin and HCB-treated mice which were infected with malaria or Leishmania and then evaluated for their ability to produce antibody to SRBC, a suppressive synergism was noted primarily in HCB-treated mice ( Table 2 ). In these mice, the splenic plaque forming response was more suppressed in the combination of HCB + infected mice than in those only HCB-treated or only infected. In dieldrin-treated mice, a synergism was observed only in mice which received 5 ppm of dieldrin plus infection with Leishmania.
Although a suppressed SRBC response was noted in HCB-treated mice infected with either malaria or Leishmania, a decreased antibody formation to PVP, a T-independent antigen, was observed only in Leishmania-infected mice exposed to dieldrin or HCB. Malaria did not act synergistically with dieldrin or HCB to elicit an impaired response to PVP ( Table 3 ). The decreased antibody formation to PVP in dieldrin-and HCB-treated mice infected with Leishmania was time-and dose-related in dieldrin-treated mice but was only time-related in HCB-treated mice.
An examination of the number of splenic T-cells, B-cells and macrophages revealed no consistent significant alterations in the cell types in either Environmental Health Perspectives did not alter PHA responsiveness. The dieldrin + Leishmania-induced impairment in PHA activity was time-and dose-related, whereas the change seen in HCB + Leishmania-infected animals was only time-related, i.e., exacerbation with extended dietary administration of HCB.
To further evaluate the impaired PHA responsiveness in dieldrin-treated mice infected with Leishmania, the splenic T-cell enriched population was subjected to mitomycin C and anti-theta (anti-T hy-1) serum. Mitomycin C and anti-theta serum abolished the mitogenic response to PHA, as measured by 3H-thymidine incorporation. When splenic T-cells taken from dieldrin + Leishmania infected mice were added at one-half the normal cell concenFebruary 1982 tration (4 x 105) to normal (control) splenic T-cells a significant inhibition was demonstrated (Tables 6  and 7 . This inhibition could be blocked by pretreating the dieldrin + Leishmania-infected mouse derived T-cells with mitomycin C which suggested an active cell-mediated suppressor. Similarly, when the splenic T-cells from the dieldrin + Leishmania-infected mice were pre-treated with anti-Thy-1 antiserum their inhibitory or suppressive effect was also abolished. These data suggested the presence of a Thy-1 positive suppressor cell in the spleen of the dieldrin-treated/Leishmania-infected mice.
Since the Leishmania promastigote has been described as a parasite infecting and proliferating in macrophages it was subsequently decided to de- aCell preparations were used as previously described in Table  5 . The enriched T-cell population at a concentration of 1 x 107 cells/ml was incubated with 20 ,ug/ml of mitomycin C (Sigma) for 25 min at 37°C. The cells were washed three times with fresh medium and numbers adjusted for subsequent use. Each study was to either control T-cells or T-cells from Leishmaniainfected mice did not alter their response to PHA, however, when added to T-cells from dieldrin-or HCB-treated mice or from dieldrin/Leishmaniainfected mice, the supernatant suppressed the T-cell response to PHA (Table 8) . Supernatant from macrophage populations from dieldrin-treated mice or Leishmania-infected mice did not alter the response to PHA. The suppressive activity was removed from the supernatant when dialyzed against phosphate-buffered saline overnight at 4°C. The production by hepatic Kupffer cells, and to a lesser extent splenic macrophages, of a suppressive Environmental Health Perspectives factor which impaired T-cell responses to PHA was correlated with the ability of hepatic macrophage from dieldrin/Leishmania treated mice to process an antigen and to transfer an adequate immunogen to a recipient control animal. Similar alterations were observed with splenic macrophages but to a lesser degree ( Table 9 ). The impaired antigen processing capability was correlated with dietary exposure time.
Discussion
Extensive interest in immunotoxicology has been generated within the past 5-6 years by the demonstration that various environmental chemical contaminants may, in laboratory situations, be immunosuppressive. However, apart from contact dermatitis, clinical evidence indicating environmental chemical-induced immune alteration has not been available; although several examples of autoimmune diseases generated by chemical exposure have been reported (12, 13) .
Experimental immunotoxicologic data have primarily focused on evaluating the immunosuppressive effect of various environmental chemical (14) .
In the present study host defense mechanisms were more significantly impaired in dieldrin-treated mice than in mice receiving HCB. Indeed, the Leishmania model did appear to be a more sensitive indicator of immunotoxicity since mice bearing this parasite had a marked lethality whether treated with dieldrin or HCB (Table 1) . However, immunosuppressive synergism to a T-dependent antigen, SRBC, in the parasite and chemical-treated mice was more evident in mice exposed to HCB than to dieldrin (Table 2) . It appeared that the chemical and not the parasite was the determining factor in the antibody response to SRBC. However, when a T-independent antigen was used, i.e., PVP, the only statistically significant immunosuppressive synergism occurred in dieldrin and HCB-treated mice 96 bearing the Leishmania parasite. Since the antibody response to PVP has been reported to be macrophage-independent (15) Isolated hepatic, and to a lesser extent splenic, macrophages produced a dialyzable factor that when added with PHA to splenic T-cell cultures, suppressed PHA stimulation of the T-cells. This macrophage T-cell suppressor factor did not influence normal control cells nor T-cells from Leishmania infected mice. However, when added to T-cells from dieldrin/Leishmania mice or dieldrin or HCBtreated mice it inhibited their proliferative response. The inhibition seen in HCB derived T-cells suggests that the factor may act on organohalideprimed cells. Although activated macrophages have been demonstrated to secrete inhibitory factors (17) previous studies have shown that macrophages from organohalide xenobiotics are not activated (4) . Indeed, as observed in Table 9 , the inability of the macrophages to present an adequate immunogen to naive hosts indicates a suppressed state.
The demonstration that maximal suppressor factor was found associated with hepatic Kupffer cells may be, in part, related to hepatotoxicity of the two xenobiotics. If this is the case, it may provide a Environmental Health Perspectives valuable tool in the study of the relationship between hepatotoxicity and immunosuppression. Further studies to elucidate the factor produced by the suppressor macrophages will evaluate interferon production as well as prostaglandins which have immunomodulatory roles (18) . In addition, macrophage secreted factors may also compete with thymidine for its uptake into DNA by T-cells.
The incorporation of infectious disease models into immunotoxicologic studies may be a more relevant as well as more sensitive indicator of immunotoxicity. Although most studies have utilized mature animals, the use of neonates and aged animals in conjunction with stress may be a more accurate measurement of immune potential.
